Mouse Anti-SARS-CoV-2(2019-nCoV) Spike glycoprotein S4 Antibody (AA 819-919)
Cat: MO-NAB-00883W
Certificate of Analysis Lookup
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number
| Size: | |
| Conjugate: | |
| Inquiry |
- Product Details
Specifications
| Host species | Mouse (Mus musculus) |
| Species Reactivity | SARS-CoV-2 (2019-nCoV) |
| Clone | NW0806 |
| Specificity | Identify SARS-CoV-2 spike glycoprotein |
| Immunogen | Recombinant SARS-CoV-2 (2019-nCoV) spike protein fragment 4[819-919] |
| Epitope | AA 819-919 |
| Format | Liquid or Lyophilized |
| Buffer | PBS, pH7.4, 50% glycerol |
| Storage | Store at 4°C: short-term (1-2weeks) Store at -20°C: long-term and future use |
Application Information
| Application | WB |
| Application Notes | WB: 1:1000-4000 |
Target
| Introduction | Coronaviruses contain at least four structural proteins: Spike (S) protein, envelope (E) protein, membrane (M) protein, and nucleocapsid (N) protein. Cell entry of coronaviruses depends on binding of the viral spike (S) proteins to cellular receptors and on S protein priming by host cell proteases. Early studies indicate that SARS-CoV-2 uses the SARS-CoV receptor angiotensin-converting enzyme 2 (ACE2) for entry and transmembrane protease serine 2 (TMPRSS2) for S protein priming. |
| Product Overview | This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant SARS-CoV-2(2019-nCoV) Spike glycoprotein. |
| Alternative Names | Spike glycoprotein; S glycoprotei; E2; Peplomer protein; Spike protein S1; Spike protein S2; Spike protein S2; S |
| UniProt ID | P0DTC2 |
For Research Use Only | Not For Clinical Use.
Online Inquiry